2020 Annual Meeting of Stockholders slide image

2020 Annual Meeting of Stockholders

Baxter Profile: A Diversified Global Portfolio¹ 2019 Global Revenue Baxter $11.4B Americas EMEA Asia Pacific 54% 26% 20% ~$3.6B ~$2.2B Renal Care Amia ~$0.9B Pharmaceuticals ¹Sales and related figures represent FY 2019; Other sales represent ~$0.5B. Pybracherite in wa Advanced Surgery ~$0.9B Baxter Critical Care NaCl 0.9% 125 ~$2.8B Medication Delivery ~$0.5B m/hr K CUMP Clinical Nutrition Acute Therapies 12
View entire presentation